Inovio Shares Off 4% After EORTC Trial Enrollment Will Not Go Through

By: via Benzinga
Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading lower by nearly 4 percent Tuesday morning after the company issued a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.